Macular atrophy after aflibercept therapy for neovascular age-related macular degeneration: outcomes of Japanese multicenter study.

Hideki KoizumiAkiko YamamotoMasashi OgasawaraIchiro MarukoTaiji HasegawaKanako ItagakiTetsuju SekiryuAnnabelle A OkadaTomohiro Iida

Published in: Japanese journal of ophthalmology (2020)

Our study determined the incidence and rate of growth of macular atrophy after IVAs for neovascular AMD in clinical settings. Eyes with vision reduction and intraretinal fluid at the baseline develop macular atrophy more frequently after IVAs for neovascular AMD.

Keyphrases

age related macular degeneration
optical coherence tomography
risk factors
type diabetes
metabolic syndrome
diabetic retinopathy
insulin resistance
weight loss